Jacob Sands

Trials

Studies that name Jacob Sands as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:51 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07149363 · Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

  Alliance Foundation Trials, LLC. · recruiting · Small Cell Lung Cancer (SCLC) · study chair
• N/A
  NCT07075627 · A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

  Addario Lung Cancer Medical Institute · withdrawn · Small Cell Lung Cancer ( SCLC ), Lambert Eaton Myasthenic Syndrome (LEMS) · principal investigator
• Ph2
  NCT03402880 · ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer

  City of Hope Medical Center · withdrawn · Extensive Stage Small Cell Lung Carcinoma · principal investigator
• Ph2
  NCT02899728 · Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

  National Cancer Institute (NCI) · terminated · Extensive Stage Lung Small Cell Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 20:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Extension of the Dana Farber Harvard Cancer Center Consortium for the ETCTN
  UM1CA186709 · NCI · DANA-FARBER CANCER INST · PI KEITH T FLAHERTY, DONALD W. KUFE, Geoffrey I. Shapiro · fiscal years 2014 to 2026
  Named on NCT02899728